XML 74 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenues $ 12,807 $ 13,542 $ 31,530 $ 45,694
Costs and expenses:        
Manufacture and supply $ 4,506 $ 4,437 $ 12,719 $ 13,352
Cost, Product and Service [Extensible Enumeration] Proprietary product revenue, net Proprietary product revenue, net Proprietary product revenue, net Proprietary product revenue, net
Research and development $ 4,530 $ 5,269 $ 13,996 $ 15,363
Selling, general and administrative 15,250 12,126 47,027 34,171
Total costs and expenses 24,286 21,832 73,742 62,886
Loss from operations (11,479) (8,290) (42,212) (17,192)
Other income/(expenses):        
Interest expense (2,779) (2,780) (8,342) (8,343)
Interest expense related to royalty obligations (1,433) (1,359) (4,304) (4,075)
Interest expense related to the sale of future revenue (61) (59) (181) (175)
Interest income and other income, net 306 979 3,115 2,703
Net loss before income taxes (15,446) (11,509) (51,924) (27,082)
Net loss (15,446) (11,509) (51,924) (27,082)
Comprehensive loss $ (15,446) $ (11,509) $ (51,924) $ (27,082)
Loss per share attributable to common stockholders:        
Basic (in dollars per share) $ (0.14) $ (0.13) $ (0.51) $ (0.32)
Diluted (in dollars per share) $ (0.14) $ (0.13) $ (0.51) $ (0.32)
Weighted average common shares outstanding:        
Basic (in shares) 110,584,371 91,082,081 101,857,974 85,224,263
Diluted (in shares) 110,584,371 91,082,081 101,857,974 85,224,263